Xylem (XYL) PT Lowered to $82 at BMO Capital
Tweet
Share
E-mailGet Alerts XYL Hot Sheet
Price: $101.53 +0.59%
Rating Summary:
18 Buy, 23 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 10 | New: 28
Rating Summary:
18 Buy, 23 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 10 | New: 28
Join SI Premium – FREE
BMO Capital analyst R. Scott Graham lowered the price target on Xylem (NYSE: XYL) to $82.00 (from $84.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MongoDB (MDB) PT Lowered to $420 at BMO Capital, 'a positive for the narrative'
- Annexon Biosciences (ANNX) PT Raised to $15 at JPMorgan
- Zenas Biopharma (ZBIO) PT Raised to $48 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
